[Positive and negative effects of cytostatic therapy in rheumatic patients].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D002699:Chlorambucil / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011035:Podophyllum / Q000009:adverse effects / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014228:Triaziquone / Q000009:adverse effects / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D015122:Mercaptopurine; D014228:Triaziquone; D001379:Azathioprine; D008727:Methotrexate
Pizitivni i negativni efekti citostaticke terapije kod reumatskih bolesnika.